Solutions Overview

Decision-Grade Evidence for Treatments

Fragmented care produces fragmented evidence. Site-based registries and passive claims datasets routinely miss clinically relevant visits, treatment history, and patient-reported data, creating gaps that undermine the scientific defensibility of real-world treatment evidence used in regulatory and market access submissions.

See how a direct relationship with the patient delivers complete longitudinal treatment journeys — 30–50% more cost-effectively than traditional site-based models — from therapy initiation through post-approval commitments.